Alzheimer's Disease Research Center (ADRC), University of Washington

Welcome

Please read our COVID-19 Update for ADRC research participants

The UW Alzheimer’s Disease Research Center (ADRC) is one of a nationwide network of 30 research resource centers funded by the National Institute on Aging. ADRCs are major sources of discovery into the nature of Alzheimer’s disease and related dementias and into the development of more effective approaches to prevention, diagnosis, care, and therapy. The UW ADRC contributes to the development of shared resources that support dementia-relevant research, and coordinates research efforts with other NIH-funded programs and investigators. UW ADRC resources are designed to facilitate and empower related research efforts at UW.

The UW ADRC is closely affiliated with the UW Memory and Brain Wellness Center clinic and links the Seattle community with information and opportunities to participate in studies of Alzheimer’s disease and related disorders (Lewy Body dementia, and frontotemporal degeneration, and vascular dementia). Our busy outreach team is influential in promoting strengths-based reframing of Alzheimer’s disease and dementia-friendly communities, and they organize and promote educational public talks and events and research seminars. We support outreach and culturally adapted Alzheimer’s disease programs for Indigenous communities and clinics. Join us!

Director: Dr. Thomas J. Grabowski, MD
Program Manager: Annika Noreen, PhD, PMP

Announcements

Dimensions Magazine - Spring 2021

May 06, 2021 — Amid the challenges our whole world has faced this past year, we have been impressed and inspired by efforts of our community members to make a difference in the world of dementia research, care, and advocacy. The Spring 2021 edition of Dimensions focuses on these efforts, and more!


UW Bioengineering startup AltPep advances technology for the early detection and treatment of Alzheimer’s and other amyloid diseases

April 13, 2021 — Seattle-based biotech AltPep, which spun out of bioengineering professor Valerie Daggett’s research lab in March 2019, has developed a platform that allows for both early diagnosis and treatment of Alzheimer’s. In January it raised $23 million in Series A investment funding to advance its work. AltPep’s tools identify diseases resulting from toxic misfolded amyloid proteins.


COVID-19 Update for our Research Participants

April 09, 2021 — The UW Alzheimer’s Disease Research Center is completing Clinical Core longitudinal study visits with currently enrolled participants by telephone, video, and in-person for some parts of the annual visit. Clinical trial visits have resumed with a combination of in-person, telephone, and virtual appointments. If you have questions or concerns, please email the study coordinator directly, or contact the research team at uwadrc@uw.edu or 206-744-0588.


View the March Newsletter!

March 31, 2021 — Stay up to date on the latest community and research news, upcoming events, and support/educational programs.

Upcoming Research Events

Loading...

Loading...